Clinical Trials Directory

Trials / Completed

CompletedNCT00915096

Positron Emission Tomography (PET)-Scan in the Evaluation of High Tumor Burden Follicular Lymphoma

High Tumor Burden Follicular Lymphoma: Impact of [18F]-FDG Positron Emission Tomography (PET) in the Assessment of Treatment Response

Status
Completed
Phase
Study type
Observational
Enrollment
121 (actual)
Sponsor
Lymphoma Study Association · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to assess in a prospective series of patients with high tumor burden follicular lymphoma treated with R-CHOP, the predictive value of \[18F\]-FDG PET performed over (after 4 treatments), and at the end of the first-line treatment on progression-free survival at 2 years.

Conditions

Timeline

Start date
2007-09-18
Primary completion
2011-05-10
Completion
2013-02-08
First posted
2009-06-05
Last updated
2018-08-23

Locations

22 sites across 2 countries: France, Italy

Source: ClinicalTrials.gov record NCT00915096. Inclusion in this directory is not an endorsement.

Positron Emission Tomography (PET)-Scan in the Evaluation of High Tumor Burden Follicular Lymphoma (NCT00915096) · Clinical Trials Directory